Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ovarian Neoplasms × Thalidomide × Clear all

Sponsor

Conditions

Multiple Myeloma 33 Neoplasms, Plasma Cell 10 Prostatic Neoplasms 3 Immunoglobulin Light-chain Amyloidosis 3 Central Nervous System Neoplasms 3 Waldenstrom Macroglobulinemia 2 Sarcoma 2 Recurrence 2 Rectal Neoplasms 2 Neuroblastoma 2 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia 2 Glioma 2 Glioblastoma 2 Colorectal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Amyloidosis 2 Adenocarcinoma of Lung 2 Renal Insufficiency, Chronic 1 Renal Insufficiency 1 Polyneuropathies 1 Paraproteinemias 1 Neurotoxicity Syndromes 1 Motor Activity 1 Melanoma 1

Interventions

Paclitaxel 80 Carboplatin 76 Bevacizumab 53 Gemcitabine 29 pembrolizumab 27 liposomal doxorubicin 27 Topotecan 22 olaparib 19 Taxes 17 niraparib 15 Docetaxel 15 Immunoglobulin G 14 Disulfides 14 Cyclophosphamide 14 Cisplatin 11 durvalumab 10 Nivolumab 9 Doxorubicin 8 Albumin-Bound Paclitaxel 8 sargramostim 7 rucaparib 7 fludarabine phosphate 7 fludarabine 7 pazopanib 6 epacadostat 6 avelumab 6 Trabectedin 6 Magnetic Resonance Spectroscopy 6 Ipilimumab 6 Interleukin-2 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡